S
Silk Therapeutics
Intensive Vitamin C Treatment to Diminish Wrinkles
About Silk Therapeutics
Silk Therapeutics, Inc. operates in the skincare sector, providing products based on its proprietary liquid silk technology platform. The company was developed by co-founders with expertise in the use of silk for health and wellness applications.
The firm's offerings include a range of skincare products such as trial kits, daily treatments, and targeted solutions. The business model appears to be direct-to-consumer, with a focus on online sales and distribution through spas and dermatologists' offices. This strategy allows the company to reach consumers who are actively seeking advanced skincare solutions and professional advice.
The target market includes individuals looking for anti-aging and skin health products. The company emphasizes the scientific and engineering investment behind its products, positioning itself in the premium skincare segment. The use of silk protein as a key ingredient is a primary differentiator in a competitive market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Medford, United States
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 27.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Oct 2018 | $30M | $120M | The Kraft Group | — |
| SERIES AOther financing | Sep 2017 | $11M | $44M | Undisclosed | — |
Growth signals
Latest recorded traffic for Silk Therapeutics is 590 monthly website visits, up 78.8% over the last three months. Silk Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
The Kraft Group
Other known investors1 additional known investor
Tufts University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Silk Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Silk Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.